BrightSpring Health EBITDA Surges 44% as Company Raises 2026 Guidance

Key Facts

1BrightSpring Health reported 23% revenue growth and a 44% surge in adjusted EBITDA for the second quarter.

2Management raised full-year 2026 guidance for both revenue and adjusted EBITDA.

In a move reflecting strong operational performance within the specialized healthcare services sector, BrightSpring Health Services announced robust second-quarter financial results. According to reports, the company achieved 23% revenue growth and a 44% surge in adjusted EBITDA. This momentum is primarily driven by expanding Provider Services and rapid improvements in overall profitability.

Following these results, management raised full-year 2026 guidance for both revenue and adjusted EBITDA, bolstering confidence in its future growth trajectory. Analytical data suggests the company has successfully reduced financial leverage, making its valuation multiples appear attractive relative to growth rates seen in its pharmaceutical solutions and home healthcare segments.

Regarding market performance, BTSG shares stood at $61.99 (at close September 09, 2026), having reached a day high of $62.83. With no immediate sector-specific catalysts in the upcoming economic calendar, investors will focus on margin sustainability and the company's ability to meet its upwardly revised 2026 financial targets.